Page last updated: 2024-08-25

zoledronic acid and Focal Segmental Glomerulosclerosis

zoledronic acid has been researched along with Focal Segmental Glomerulosclerosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Markowitz, GS; Perazella, MA1
Amico, P; Bodmer, M; Haschke, M; Krähenbühl, S; Kummer, O; Mayr, M; Mihatsch, MJ1

Reviews

1 review(s) available for zoledronic acid and Focal Segmental Glomerulosclerosis

ArticleYear
Bisphosphonate nephrotoxicity.
    Kidney international, 2008, Volume: 74, Issue:11

    Topics: Diphosphonates; Glomerulosclerosis, Focal Segmental; Humans; Imidazoles; Kidney Cortex Necrosis; Kidney Diseases; Pamidronate; Practice Guidelines as Topic; Zoledronic Acid

2008

Other Studies

1 other study(ies) available for zoledronic acid and Focal Segmental Glomerulosclerosis

ArticleYear
Focal segmental glomerulosclerosis associated with long-term treatment with zoledronate in a myeloma patient.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:8

    Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Glomerulosclerosis, Focal Segmental; Humans; Imidazoles; Kidney; Male; Multiple Myeloma; Nephrotic Syndrome; Time Factors; Treatment Outcome; Zoledronic Acid

2007